Purchases and Sales Made in Q3 2024 in Olema Pharmaceuticals, Inc. (OLMA)
This table provides information about the institutional ownership of Olema Pharmaceuticals, Inc. (OLMA) during Q3 2024. The information is specifically focused on institutions that hold shares of Olema Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Silverarc Capital Management, LLC
|
SELL
|
- |
-91.8K- 16.78% |
$955K - $1.51M
|
455K
$2.29M
|
|
|
Nov 14, 2024
Q3 2024
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-113K- 52.19% |
$1.18M - $1.86M
|
104K
$522K
|
|
|
Nov 12, 2024
Q3 2024
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-125K- 11.81% |
$1.3M - $2.06M
|
935K
$4.71M
|
|
|
Nov 13, 2024
Q3 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-210K- 7.65% |
$2.18M - $3.45M
|
2.53M
$12.8M
|
|
|
Nov 13, 2024
Q3 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-227K- 89.31% |
$2.36M - $3.73M
|
27.1K
$137K
|
|
|
Nov 07, 2024
Q3 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-308K- 18.28% |
$3.21M - $5.07M
|
1.38M
$6.94M
|
|
|
Nov 14, 2024
Q3 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-349K- 59.19% |
$3.63M - $5.74M
|
240K
$1.21M
|
|
|
Nov 13, 2024
Q3 2024
|
Vivo Capital, LLC
Palo Alto, CA |
SELL
|
- |
-368K- 19.63% |
$3.83M - $6.05M
|
1.51M
$7.59M
|
|
|
Nov 14, 2024
Q3 2024
|
Paradigm Biocapital Advisors LP
New York, NY |
SELL
|
- |
-2.4M- 30.37% |
$25M - $39.5M
|
5.5M
$27.7M
|